Anabolic Rating
100
Standard Reference
Androgenic Rating
100
Perfect Balance
Chemical Formula
C19H28O2
Bio-Identical
Typical Half-Life
8-12 Days
Enanthate/Cypionate
Anabolic Baseline
100pts
Androgenic Ref
100pts
Dermatological
Acne, Oily Skin, Seborrhea
Follicular
DHT-induced Alopecia
Systemic
Fluid Retention (Edema)
Neurological
Insomnia & Sleep Apnea
Cardiovascular
LVH & Arterial Stiffness
Endocrine
HPTA Shutdown & Atrophy
Hepatic
Transaminase Elevation
Hematology
Erythrocytosis (HCT > 54%)
Heavy Compound Loading
Squats/Deadlifts trigger acute hormonal spikes.
Circadian Alignment
90% of T-production occurs during REM sleep cycles.
Adipose Regulation
Lower body fat reduces Aromatase enzyme activity.
Micronutrient Loading
Targeting Zinc, Boron, and Magnesium saturation.
Ashwagandha (KSM-66)
Reduces Cortisol; +15% T-Boost
Vitamin D3 + K2
Essential for Steroidogenesis
Zinc Picolinate
Prevents LH suppression
Boron Citrate
Lowers SHBG; increases Free Test
Tongkat Ali
Stimulates Leydig cell activity
Propionate
~20-36 Hours
Enanthate
~4.5-5 Days
Cypionate
~7-8 Days
Undecanoate
~21-34 Days
PCT Intensity
Critical / Mandatory
Aromatization
High (E2 Conversion)
Blood Work
Bi-Monthly Recommended
HPTA Status
Rapid Suppression
Standard Unit
mg / Week
Method
IM / Sub-Q
Replacement Therapy
Split 2x weekly
Hypogonadism Standard
Every 7 days
Micro-Dosing Protocol
Daily (Daily Sub-Q)
Topical Absorption
Gel (10% bioavail.)
Introductory
Risk Level: Moderate
Intermediate
Risk Level: High
Advanced/Pro
Risk Level: Critical
Clomiphene (Clomid)
Pituitary Stimulant
Tamoxifen (Nolvadex)
Receptor Antagonist
hCG (Pregnyl)
Gonadotropin
The Clearance Window
Wait 14-21 days after last pin
Allowing ester concentrations to drop below supraphysiological levels.
Weeks 1 - 2
Front-Loading SERMs
High-dose phase to aggressively signal the Pituitary gland.
Weeks 3 - 6
Maintenance Phase
Tapering dosage while monitoring natural libido and mood.
Month 3+
The Final Baseline
Blood work check: Total T, Free T, LH, FSH, and SHBG.
Wk 0
Baseline
Full metabolic & hormonal screen.
Wk 6
Mid-Check
Check E2 and Hematocrit levels.
Wk 12
Post-Cycle
Identify LH/FSH suppression levels.
Wk 20
Recovery
Verify HPTA restart after PCT.
// STATUTORY NOTICE: THIS INFORMATION IS DISTRIBUTED FOR EDUCATIONAL AND HARM-REDUCTION PURPOSES ONLY. IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
// CLINICAL REQUIREMENT: EXOGENOUS HORMONE USE WITHOUT A VALID DOCTOR'S PRESCRIPTION IS ILLEGAL AND MEDICALLY HAZARDOUS. UNDERGROUND LABS (UGL) PRODUCTS POSE RISKS OF SEPSIS, HEAVY METAL TOXICITY, AND SUBSTANDARD DOSING.
// INDIVIDUAL VARIABILITY: BIOCHEMICAL INDIVIDUALITY MEANS NO PROTOCOL IS UNIVERSAL. AGE, PRE-EXISTING CARDIAC CONDITIONS, AND GENETIC PREDISPOSITION TO ALOPECIA OR GYNECOMASTIA MUST BE EVALUATED BY A LICENSED ENDOCRINOLOGIST.